Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals

BACKGROUND/AIMS: Undetectable HCV RNA 12 weeks after the end of treatment (SVR12) has been the valid efficacy endpoint in the era of direct-acting antivirals (DAAs). Its concordance with SVR4 and SVR24 and long-term durability is unknown in Taiwanese chronic hepatitis C (CHC) patients. METHODS: A to...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:PLoS One
Main Authors: Lin, Chuan-Pin, Liang, Po-Cheng, Huang, Ching-I, Yeh, Ming-Lun, Hsu, Po-Yao, Hsu, Cheng-Ting, Wei, Yu-Ju, Liu, Ta-Wei, Hsieh, Ming-Yen, Hou, Nai-Jen, Jang, Tyng-Yuang, Lin, Yi-Hung, Wang, Chih-Wen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Chung-Feng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
פורמט: Artigo
שפה:Inglês
יצא לאור: Public Library of Science 2021
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7861540/
https://ncbi.nlm.nih.gov/pubmed/33539408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0245479
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים